Show results for
Refine by
Mrna Suppliers Serving Botswana
81 companies found
based inSan Diego, CALIFORNIA (USA)
Element Biosciences, founded in 2017 and headquartered in San Diego, California, is a multidisciplinary startup revolutionizing genetic analysis tools for the research market. The company focuses on developing innovative and affordable sequencing ...
based inSingapore, SINGAPORE
Based in Singapore, Lumina Scientific Asia applies its more-than-15 years-experience to provide our customers with honest, knowledgeable advice. In our search for improvements in the imaging research field, we continuously source the latest ...
based inSpringfield, PENNSYLVANIA (USA)
At FireGene, we develop, manufacture, and supply a wide range of products and services including nucleic acid isolation and purification kits, molecular diagnostic kits, molecular biology reagents, ELISA kits, NGS library preparation kits, etc. We ...
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
The StemRNA 3rd Gen Reprogramming Kit provides the fastest, most efficient method for generating clinically relevant iPS cells using a non-integrating, mRNA-based protocol. This technology supports generating iPSC lines derived from ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
The 3D InSight™ Steatosis Model is an advanced human disease model that enables you to screen compounds and investigate disease pathophysiology using a physiologically relevant human liver microtissue that recapitulates the first stage of ...
based inCambridge, MASSACHUSETTS (USA)
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. ...
Our scientists are developing mRNA medicines to help prevent or treat ...
based inDelhi, INDIA
Premas Life Sciences (PLS) is a young, dynamic, and focused organization introducing game-changing niche technologies in Genomics, Cell Biology, and Biopharma to boost innovative research and diagnostics in India. We are also the knowledge partners ...
Visium Spatial Gene Expression is a next-generation molecular technology for classifying tissue based on total mRNA. Map the whole transcriptome with morphological context to discover novel insights into normal development, disease ...
based inMenlo Park,, CALIFORNIA (USA)
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. Based on a foundation of engineering and chemistry, Synthego leverages automation and machine ...
based inBerlin, GERMANY
Scientists around the world are working to leap ahead of diseases and to improve our lives with innovation. Aside from brilliant minds and relentless passion, the success of science depends on the quality of the materials used. biotechrabbit is ...
based inGent, BELGIUM
RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves companies time and money, guarantees product quality and offers the supply chain greater flexibility, compared to ...
based inShipley, UNITED KINGDOM
Our founders have more than 50 years of experience in the field of protein and antibody research. They are experts in this niche market and the main purpose behind the creation of this company was to offer customers with the highest quality ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
Plasmid DNA is a critical raw material for advanced therapeutics including mRNA- and viral vector-based cell and gene therapies and vaccines. To support your therapeutic programs, the Catalent team has broad expertise in developing ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
based inKAARINA, FINLAND
Labmaster Oy Ltd. is a company engaged in the design, development, and manufacturing of various products, ensuring they meet specified criteria through proper storage, usage, and transportation guidelines. They emphasize adherence to instructions ...
The Labmaster LUCIA™ SARS-CoV-2 IgG RBD test is meant for in vitro diagnostic qualitative detection of the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain IgG antibodies from whole blood samples ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
Messenger ribonucleic acid (mRNA) vaccines are a novel technology that stimulate the body’s own immune response. These vaccines contain information from messenger RNA, including the “blueprint” or code of a ...
based inTirat Carmel, ISRAEL
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time. MeMed’s interdisciplinary ...
We have been collaborating with leading clinicians, scientists and commercial partners around the globe to develop and validate a proprietary set of rapid blood tests with the aim of empowering physicians to tackle some of the most challenging ...
based inZhubei, TAIWAN
QuarkBio strives to become a global leader in providing high quality precision healthcare solutions to our partners through our core technologies by maintaining a strong connection between the latest research findings and the needs of both doctors ...
Choose NextAmp™ Analysis System to optimize biomarker selection and to accelerate the clinical research towards next precision medicine ...
based inBielefeld, GERMANY
PlasmidFactory GmbH & Co. KG is a globally active biopharmaceutical company, founded in Bielefeld, Germany, in 2000. The leading contract manufacturing organization (CMO) for plasmid and minicircle DNA has a strong customer base in the fields of ...
In particular, the High Quality Grade production of plasmid DNA as a starting material for the production of RNA vaccines has gained in importance, especially in the context of the COVID-19 pandemic, as RNA is considered a promising vaccine for the ...